|
1
|
Chow WH and Devesa SS: Contemporary
epidemiology of renal cell cancer. Cancer J. 14:288–301. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iliopoulos O: Molecular biology of renal
cell cancer and the identification of therapeutic targets. J Clin
Oncol. 24:5593–5600. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu WS, Liu YD, Fu Q, Zhang WJ, Xu L,
Chang Y and Xu JJ: Prognostic significance of ubiquinol-cytochrome
c reductase hinge protein expression in patients with clear cell
renal cell carcinoma. Am J Cancer Res. 6:797–805. 2016.PubMed/NCBI
|
|
4
|
Xiang C, Cui SP and Ke Y: MiR-144 inhibits
cell proliferation of renal cell carcinoma by targeting MTOR. J
Huazhong Univ Sci Technolog Med Sci. 36:186–192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu Z, Ni L, Chen D, Su Z, Yu W, Zhang Q,
Wang Y, Li C, Gui Y and Lai Y: Expression and clinical significance
of RCDG1 in renal cell carcinoma: A novel renal cancer-associated
gene. Mol Med Rep. 10:1583–1589. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang Z, Chu PG, Woda BA, Rock KL, Liu Q,
Hsieh CC, Li C, Chen W, Duan HO, McDougal S and Wu CL: Analysis of
RNA-binding protein IMP3 to predict metastasis and prognosis of
renal-cell carcinoma: A retrospective study. Lancet Oncol.
7:556–564. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou X, Chen J and Tang W: The molecular
mechanism of HOTAIR in tumorigenesis, metastasis, and drug
resistance. Acta Biochim Biophys Sin (Shanghai). 46:1011–1015.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iranpour M, Soudyab M, Geranpayeh L,
Mirfakhraie R, Azargashb E, Movafagh A and Ghafouri-Fard S:
Expression analysis of four long noncoding RNAs in breast cancer.
Tumour Biol. 37:2933–2940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lan WG, Xu DH, Xu C, Ding CL, Ning FL,
Zhou YL, Ma LB, Liu CM and Han X: Silencing of long non-coding RNA
ANRIL inhibits the development of multidrug resistance in gastric
cancer cells. Oncol Rep. 36:263–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Melissari MT and Grote P: Roles for long
non-coding RNAs in physiology and disease. Pflugers Arch.
468:945–958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cui M, You L, Ren X, Zhao W, Liao Q and
Zhao Y: Long non-coding RNA PVT1 and cancer. Biochem Biophys Res
Commun. 471:10–14. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nowacki M, Vijayan V, Zhou Y, Schotanus K,
Doak TG and Landweber LF: RNA-mediated epigenetic programming of a
genome-rearrangement pathway. Nature. 451:153–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pandey RR, Mondal T, Mohammad F, Enroth S,
Redrup L, Komorowski J, Nagano T, Mancini-Dinardo D and Kanduri C:
Kcnq1ot1 antisense noncoding RNA mediates lineage-specific
transcriptional silencing through chromatin-level regulation. Mol
Cell. 32:232–246. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mourtada-Maarabouni M, Pickard MR, Hedge
VL, Farzaneh F and Williams GT: GAS5, a non-protein-coding RNA,
controls apoptosis and is downregulated in breast cancer. Oncogene.
28:195–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Autuoro JM, Pirnie SP and Carmichael GG:
Long noncoding RNAs in imprinting and X chromosome inactivation.
Biomolecules. 4:76–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu SP, Zhang JF, Sui SY, Bai NX, Gao S,
Zhang GW, Shi QY, You ZL, Zhan C and Pang D: Downregulation of the
long noncoding RNA EGOT correlates with malignant status and poor
prognosis in breast cancer. Tumour Biol. 36:9807–9812. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Malouf GG, Zhang J, Yuan Y, Compérat E,
Rouprêt M, Cussenot O, Chen Y, Thompson EJ, Tannir NM, Weinstein
JN, et al: Characterization of long non-coding RNA transcriptome in
clear-cell renal cell carcinoma by next-generation deep sequencing.
Mol Oncol. 9:32–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kunej T, Obsteter J, Pogacar Z, Horvat S
and Calin GA: The decalog of long non-coding RNA involvement in
cancer diagnosis and monitoring. Crit Rev Clin Lab Sci. 51:344–357.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blondeau JJ, Deng M, Syring I, Schrödter
S, Schmidt D, Perner S, Müller SC and Ellinger J: Identification of
novel long non-coding RNAs in clear cell renal cell carcinoma. Clin
Epigenetics. 7:102015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qin C, Han Z, Qian J, Bao M, Li P, Ju X,
Zhang S, Zhang L, Li S, Cao Q, et al: Expression pattern of long
non-coding RNAs in renal cell carcinoma revealed by microarray.
PLoS One. 9:e993722014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Z, Yan HY, Xia SY, Zhang C and Xiu YC:
Downregulation of long non-coding RNA TRIM52-AS1 functions as a
tumor suppressor in renal cell carcinoma. Mol Med Rep.
13:3206–3212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang M, Huang T, Luo G, Huang C, Xiao XY,
Wang L, Jiang GS and Zeng FQ: Long non-coding RNA MEG3 induces
renal cell carcinoma cells apoptosis by activating the
mitochondrial pathway. J Huazhong Univ Sci Technolog Med Sci.
35:541–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wagner LA, Christensen CJ, Dunn DM,
Spangrude GJ, Georgelas A, Kelley L, Esplin MS, Weiss RB and Gleich
GJ: EGO, a novel, noncoding RNA gene, regulates eosinophil granule
protein transcript expression. Blood. 109:5191–5198. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang HM, Yang FQ, Chen SJ, Che J and
Zheng JH: Upregulation of long non-coding RNA MALAT1 correlates
with tumor progression and poor prognosis in clear cell renal cell
carcinoma. Tumour Biol. 36:2947–2955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Y, Wang T, Li Y, Chen D, Yu Z, Jin L,
Ni L, Yang S, Mao X, Gui Y and Lai Y: Identification of long-non
coding RNA UCA1 as an oncogene in renal cell carcinoma. Mol Med
Rep. 13:3326–3334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pei CS, Wu HY, Fan FT, Wu Y, Shen CS and
Pan LQ: Influence of curcumin on HOTAIR-mediated migration of human
renal cell carcinoma cells. Asian Pac J Cancer Prev. 15:4239–4243.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu Y, Liu J, Zheng Y, You L, Kuang D and
Liu T: Suppressed expression of long non-coding RNA HOTAIR inhibits
proliferation and tumourigenicity of renal carcinoma cells. Tumour
Biol. 35:11887–11894. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song S, Wu Z, Wang C, Liu B, Ye X, Chen J,
Yang Q, Ye H, Xu B and Wang L: RCCRT1 is correlated with prognosis
and promotes cell migration and invasion in renal cell carcinoma.
Urology. 84:730.e1–e7. 2014. View Article : Google Scholar
|
|
32
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cao Y, Xu R, Xu X, Zhou Y, Cui L and He X:
Downregulation of lncRNA CASC2 by microRNA-21 increases the
proliferation and migration of renal cell carcinoma cells. Mol Med
Rep. 14:1019–1025. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhai W, Sun Y, Jiang M, Wang M, Gasiewicz
TA, Zheng J and Chang C: Differential regulation of lncRNA-SARCC
suppresses VHL-mutant RCC cell proliferation yet promotes
VHL-normal RCC cell proliferation via modulating androgen
receptor/HIF-2α/C-MYC axis under hypoxia. Oncogene. 35:4866–4880.
2016. View Article : Google Scholar : PubMed/NCBI
|
